-
公开(公告)号:US20120201749A1
公开(公告)日:2012-08-09
申请号:US13391686
申请日:2010-08-25
申请人: Melanie Jayne Crawshaw , Philip Spencer Fallon , Ashley Nicholas Jarvis , Jonathan Raymond Powell , Natalie Louise Winfield , David Selwood , Ian Charles Zachary , Haiyan Jia
发明人: Melanie Jayne Crawshaw , Philip Spencer Fallon , Ashley Nicholas Jarvis , Jonathan Raymond Powell , Natalie Louise Winfield , David Selwood , Ian Charles Zachary , Haiyan Jia
IPC分类号: A61K31/4535 , A61K31/496 , A61K31/4436 , C07D413/14 , A61K49/10 , A61P25/28 , A61P35/00 , A61P37/00 , A61K51/00 , C07D409/14 , A61K31/5377
CPC分类号: C07D417/12 , C07D333/36 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/14
摘要: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein: W is arylene, heteroarylene or formula (a) each L is independently alkylene, alkenylene, alkynylene, a direct bond, arylene, cycloalkylene, alkylene-arylene, alkylene-C═O or —C═O; each X is independently an N-containing heteroarylene, N-containing cycloalkylene or NR; Y is N-containing heteroaryl, N-containing cycloalkyl, NR2, OR1, CN or CO2R; Z1 is formula (b); are useful in therapy, particularly in the therapy of neurodegeneration and cancer.
摘要翻译: 式(I)化合物或其药学上可接受的盐,其中:W是亚芳基,亚杂芳基或式(a),每个L独立地是亚烷基,亚烯基,亚炔基,直接键,亚芳基,亚环烷基,亚烷基亚芳基, C = O或-C = O; 每个X独立地是含N的杂亚芳基,含N的亚环烷基或NR; Y是含N的杂芳基,含N的环烷基,NR2,OR1,CN或CO2R; Z1是式(b); 可用于治疗,特别是治疗神经变性和癌症。
-
公开(公告)号:US20090274650A1
公开(公告)日:2009-11-05
申请号:US12370175
申请日:2009-02-12
申请人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger , Ronald George Sherrill
发明人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger , Ronald George Sherrill
IPC分类号: A61K31/443 , C07D493/04 , C07D413/12 , C07D317/46 , A61K31/5377 , A61K31/357 , A61K31/34 , A61K31/52 , A61K31/522 , A61K31/496 , A61K31/427 , A61K31/472 , A61K31/513 , A61K31/708 , A61K38/21 , A61K38/20 , A61P31/12 , A61P31/18
CPC分类号: C07D493/04 , A61K31/352 , A61K31/36 , A61K45/06 , C07D317/46 , A61K2300/00
摘要: The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
摘要翻译: 本发明涉及一类新型的磺酰胺,它们是天冬氨酰蛋白酶抑制剂。 在一个实施方案中,本发明涉及以特定结构和物理化学特征为特征的新型HIV天冬氨酰蛋白酶抑制剂。 本发明还涉及包含这些化合物的药物组合物。 本发明的化合物和药物组合物特别适用于抑制HIV-1和HIV-2蛋白酶活性,因此可有利地用作针对HIV-1和HIV-2病毒的抗病毒剂。 本发明还涉及使用本发明化合物抑制HIV天冬氨酰蛋白酶活性的方法和用于筛选抗HIV活性化合物的方法。
-
3.
公开(公告)号:US07129355B2
公开(公告)日:2006-10-31
申请号:US10615044
申请日:2003-07-08
申请人: Paul Andrew Benjes , Ashley Nicholas Jarvis , Gary Brian Evans , Gavin Frank Painter , John Adrian Dickison , Anthony Mitchell , Keith Clinch
发明人: Paul Andrew Benjes , Ashley Nicholas Jarvis , Gary Brian Evans , Gavin Frank Painter , John Adrian Dickison , Anthony Mitchell , Keith Clinch
IPC分类号: C07D471/02 , C07D319/12 , C07D317/00
CPC分类号: C07D407/04 , Y02P20/55
摘要: A novel method for the preparation of a compound of formula (I) from an N—protected-D-mannosamine. A compound of formula (I) is a useful intermediate for the preparation of kiftnensine, a potent and selective mannosidase inhibitor. The method includes protecting the hydroxyl group at the C-6 position of an N—protected-D-mannosamine, to give a 6—O—protected—N—protected-D-mannosamine; reducing the C-1 anomeric carbon atom of the 6—O—protected—N—protected-D-mannosamine to give a 6—O—protected—N—protected-D-mannitol; protecting the four hydroxyl groups of the 6—O—protected—N—protected-D-mannitol; and removing the nitrogen atom protecting group and optionally removing the C-6 oxygen atom protecting group to give the compound of formula (I): where R1 and R2 are each independently protecting groups which, together with the oxygen atoms to which they are attached, form a 5-, 6-, 7- or 8-membered ring; and R3 is hydrogen or a protecting group.
摘要翻译: 一种从N-保护的D-甘露糖胺制备式(I)化合物的新方法。 式(I)化合物是用于制备功能性和选择性甘露糖苷酶抑制剂的kiftnensine的有用中间体。 该方法包括保护N-保护的D-甘露糖胺C-6位的羟基,得到6-O-保护的N-保护的D-甘露糖胺; 还原6-O-保护的N-保护的D-甘露糖胺的C-1端基异构体碳原子,得到6-O-保护的N-保护的D-甘露糖醇; 保护6-O-保护的N-保护的D-甘露糖醇的四个羟基; 除去氮原子保护基,任选地除去C-6氧原子保护基,得到式(I)化合物:其中R 1和R 2各自为 独立地保护与它们所连接的氧原子一起形成5-,6-,7-或8-元环的基团; R 3是氢或保护基。
-
公开(公告)号:US08455497B2
公开(公告)日:2013-06-04
申请号:US12370175
申请日:2009-02-12
申请人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger , Ronald George Sherrill
发明人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger , Ronald George Sherrill
IPC分类号: C07D493/04 , A61K31/34 , A61K31/357 , A61K31/36 , A61P31/18 , C07C311/16 , C07C311/29
CPC分类号: C07D493/04 , A61K31/352 , A61K31/36 , A61K45/06 , C07D317/46 , A61K2300/00
摘要: The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
-
公开(公告)号:US06878728B1
公开(公告)日:2005-04-12
申请号:US09591464
申请日:2000-06-09
申请人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger
发明人: Michael R. Hale , Roger Tung , Stephen Price , Robin David Wilkes , Wayne Carl Schairer , Ashley Nicholas Jarvis , Andrew Spaltenstein , Eric Steven Furfine , Vicente Samano , Istvan Kaldor , John Franklin Miller , Michael Stephen Brieger
IPC分类号: A61K31/352 , A61K31/36 , A61K45/06 , A61K31/454 , A61K31/422 , C07D413/14 , C07D417/12
CPC分类号: C07D493/04 , A61K31/352 , A61K31/36 , A61K45/06 , C07D277/24 , C07D317/62 , C07D407/12 , A61K2300/00
摘要: The invention provides novel compounds of formula (I) wherein all variables are as defined in the specification, that are useful as inhibitors of aspartyl proteases.
摘要翻译: 本发明提供新的式(I)化合物,其中所有变量如说明书中所定义,可用作天冬氨酰蛋白酶抑制剂。
-
-
-
-